1. Home
  2. Hormonal Health & Growth
  3. CJC-1295 + Ipamorelin
CJC-1295 + Ipamorelin
Hormonal Health

CJC-1295 + Ipamorelin

CJC-1295 + Ipamorelin · Combination of two research peptides

A combination of a GHRH analogue and a growth hormone secretagogue.

Price confirmed by your advisor.

Available on request in Australia

Ask an advisor
Non-binding request. An advisor contacts you and the partner pharmacy checks whether and how it can proceed. A valid prescription, or an assessment through an authorised telemedicine service, may be required.
  • Partner pharmacy
  • Personal assistance
  • Discreet delivery

Shipping & Delivery

  • Normally dispatched within 24 hours of payment confirmation.
  • UPS Express · A$25 · Approx. 7–9 business days
  • Registered Mail · A$15 · Approx. 14–20 business days

For research use only.

Not intended for human or animal consumption, nor for medical, personal or diagnostic use. By purchasing this product, you confirm that you are qualified to handle research materials.

Research status

What is known so far

CJC-1295 is an analogue of growth hormone-releasing hormone (GHRH); ipamorelin is a growth hormone secretagogue acting on the ghrelin receptor. Neither is an authorised medicine and there are no clinical data on the combination.

It has no marketing authorisation as a medicine in this market. This page summarises the state of research and does not describe proven clinical benefits.

Documents

Product information

Patient information leafletNot available: not an authorised medicine
Summary of Product CharacteristicsNot available: not an authorised medicine
Related
Hormonal Health
  • Ngenla
    Somatrogon

    Ngenla

    Pen · 24 mg or 60 mg

    On request

    fromA$325
  • Ipamorelin
    Ipamorelin

    Ipamorelin

    Research compound · information only

    On request

  • Sermorelin
    Sermorelin

    Sermorelin

    Status under review · information only

    On request